News | September 08, 2014

MedStar Georgetown to Install Mevion S250 Proton Therapy System to Treat Adult and Pediatric Cancer Patients

MedStar Georgetown University Hospital to bring first proton therapy center to Washington, D.C.

MedStar Georgetown to Install Mevion S250 Proton Therapy System to Treat Adult and Pediatric Cancer Patients

September 8, 2014 — Mevion Medical Systems announced that MedStar Georgetown University Hospital has received final approval to begin construction of the first proton therapy center in Washington, D.C., at its Lombardi Comprehensive Cancer Center.

Georgetown Lombardi is the only cancer center in the D.C. area to earn the National Cancer Institute (NCI) designation as a comprehensive cancer center. The Mevion S250, the world’s smallest single-room proton therapy system, delivers the same precise, noninvasive treatment advantages and capabilities of larger, more expensive proton therapy systems but with a significantly reduced footprint, improved reliability, more efficient patient access, and dramatically lower implementation and operational costs.

Proton therapy is an advanced form of external radiation treatment that aims a powerful beam of protons at a tumor with incredible accuracy. Because of the special properties of protons, treatments result in less damage to surrounding healthy tissue and a reduced risk of secondary malignancies. Proton therapy is commonly used to treat a wide range of cancers in sensitive locations, such as the central nervous system, chest, head and neck, eye, and prostate. This advanced form of radiation is extremely valuable for the treatment of cancer in pediatric patients, who can be more prone to complications from radiation treatment.

Construction is scheduled to start in the fall, with installation of the Mevion S250 to be complete in 2016.

“The addition of proton therapy to our experienced and internationally known cancer program is a natural progression for us as the only provider in the region with a long history of serving both children as well as adults with cancer,” said Richard Goldberg, M.D., president, MedStar Georgetown University Hospital. “We are excited to bring this important technology to our community and to give our patients yet another cutting-edge cancer treatment option.”

“The Mevion S250 proton therapy system provides a significant benefit to cancer patients while redefining the economics and accessibility of proton therapy,” said Joseph K. Jachinowski, president and CEO of Mevion Medical Systems. “We are proud to bring the most advanced radiation therapy device to our nation’s capital and another leading healthcare institution.”

For more information: www.mevion.com, www.lombardi.georgetown.edu

Related Content

MIM Software Inc. Receives FDA 510(k) Clearance for Molecular Radiotherapy Dosimetry
Technology | Nuclear Imaging | January 16, 2019
MIM Software Inc. received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for molecular radiotherapy...
Electronic Brachytherapy Effective in Long-Term Study of 1,000 Early-Stage Breast Cancers
News | Brachytherapy Systems, Women's Healthcare | January 07, 2019
Breast cancer recurrence rates of patients treated with intraoperative radiation therapy (IORT) using the Xoft Axxent...
Brachytherapy Alone Superior Treatment for Intermediate-Risk Prostate Cancer
News | Brachytherapy Systems | January 04, 2019
Patient-reported outcomes (PROs) indicated a significantly different clinician and patient-reported late toxicity...
RayStation 8B Released With Machine Learning Applications for Treatment Planning
Technology | Treatment Planning | December 27, 2018
RaySearch Laboratories released RayStation 8B, the latest version of the radiation therapy treatment planning system (...
Axillary Radiotherapy and Lymph Node Surgery Yield Comparable Outcomes for Breast Cancer
News | Radiation Therapy | December 18, 2018
Early-stage breast cancer patients with cancer detected in a sentinel lymph node biopsy had comparable 10-year...
RaySearch Developing RayCommand Treatment Control System for U.K. Proton Therapy Facility
Technology | Radiation Therapy | December 10, 2018
RaySearch has decided to develop a treatment control system, RayCommand, to act as a link between its RayStation...
Mirada Medical Joins U.K. Consortium Exploring Healthcare AI
News | Artificial Intelligence | December 04, 2018
Mirada Medical, a leading global brand in medical imaging software, will form part of an artificial intelligence (AI)...
Sponsored Content | Videos | Radiation Oncology | November 30, 2018
Accuray's philosophy is to personalize treatments to exactly fit the patient.
Ohio State University to Open Region’s First Proton Therapy Facility

Image courtesy of The Ohio State University James Comprehensive Cancer Center

News | Proton Therapy | November 21, 2018
The Ohio State University Wexner Medical Center and the Arthur G. James Cancer Hospital and Richard J. Solove Research...